OLD Media News

Johnson & Johnson pauses COVID-19 vaccine trial

Johnson & Johnson has paused a trial for a COVID-19 vaccine after a participant developed an “unexplained illness.”

Lydia Ramsay Pflanzer reported for the Business Insider:

Johnson & Johnson said Monday that it had temporarily halted its coronavirus vaccine trials after a participant experienced an unexplained illness, the second major setback to hit a late-stage test of a coronavirus immunization.

The pharma giant said it paused all further dosing in the trials after a participant fell ill. The pause in the trial, which is aiming to enroll 60,000 people to determine if the vaccine is safe and effective, was first reported by Stat News’ Matthew Herper

Elizabeth Weise and Karen Weintraub from US Today wrote:

In any study the size of the Johnson & Johnson one, which will include up to 60,000 people when it is fully enrolled, some adverse events are expected among the participants. Such studies have clear, prespecified guidelines that say what events would trigger a shutdown. 

The independent Data Safety Monitoring Board, which oversees the trial, will review what happened and decide whether it is safe to resume the trial.

CNN’s Maggie Fox quoted the company:

“Based on our strong commitment to safety, all clinical studies conducted by the Janssen Pharmaceutical Companies of Johnson & Johnson have prespecified guidelines. These ensure our studies may be paused if an unexpected serious adverse event (SAE) that might be related to a vaccine or study drug is reported, so there can be a careful review of all of the medical information before deciding whether to restart the study,” the company said.

Irina Slav

Recent Posts

Debtwire seeks a private credit reporter

Debtwire, the leading provider of global fixed income news, analysis and data for more than…

3 mins ago

BNN Bloomberg anchor Kanwar is departing

Amber Kanwar, an anchor for BNN Bloomberg in Canada, is departing at the end of…

12 mins ago

Moody’s promotes Kantrow to editor in chief

Moody's Ratings has promoted Yvette Kantrow to senior vice president and editor in chief. She has been…

16 mins ago

Politico reporter Fieseler departs

Politico reporter Clare Fieseler is leaving the news organization to take on some ocean reporting projects. She…

21 mins ago

WSJ’s Eisen to write book about the mortgage market

Wall Street Journal reporter Ben Eisen has signed a contract with Norton to write a book about…

2 hours ago

Reuters hires Krishnakutty as a news producer

Reuters has hired Pia Krishnakutty as a news producer. She has been at The Print as a…

3 hours ago